About us
Founded in 2003, Regen Lab
has become a global reference
thanks to its commitment to innovation,
quality, and the effectiveness
of its therapeutic solutions.
Patients treated
Countries worldwide
Published studies
Research projetcs
Regen Lab SA stands as a beacon of innovation in the realm of autologous regenerative medicine. Nestled in the heart of Le Mont-sur-Lausanne, Switzerland, our company specializes in the extemporaneous preparation of Platelet-Rich Plasma (PRP) derived from the patient’s own blood. We also focus on advanced cell therapy techniques, notably the development of combined therapies such as PRP with hyaluronic acid.
In 2009, Regen Lab SA embarked on a significant milestone by inaugurating a state-of-the-art Good Manufacturing Practice (GMP) facility. This advancement has propelled us to the forefront of high-quality medical device production.
Today, our patented technologies are operational in over 160 countries, successfully treating more than 2 million patients across various therapeutic areas including musculoskeletal disorders, dermatology, wound care, and intimate health.
Our commitment to excellence is underscored by our pioneering use of a thixotropic gel for the precise separation of blood components. This innovation ensures that our cell therapy products are both standardized and reproducible. Regen Lab SA is proud to be ISO 13485 certified, with all products conforming to CE standards.
Our Mission
Regen Lab SA is devoted to advancing the frontier of regenerative medicine by delivering state-of-the-art medical devices designed to enhance patient outcomes and elevate quality of life.
Our Facilities
Our GMP-certified facility in Le Mont-sur-Lausanne epitomizes excellence in medical device manufacturing, upholding the highest standards of safety and efficacy.
Global Presence
With a robust presence in over 90 countries, Regen Lab SA is dedicated to expanding its reach, providing innovative regenerative therapies to millions of patients around the globe.
Patents Portfolio
As a leader in the PRP&HA regenerative field and as an innovation-driven company, Regen Lab SA has devoted important resources since 2004 to put on the market pioneering and diversified products constituting a complete set of tools/technologies for the medical community. Innovation represents one of the strongest pillars of the company with more than 50 in-house scientists and a unique network of talented and renowned medical doctors contributing to Regen Lab’s Research & Development.
Active Patents
Since 2003, Regen Lab SA has been committed to the development of a unique expertise for the design and manufacturing of high-quality medical devices, intended for cells therapies.